ElectroPhysiology Frontiers is a MedTech company actively developing an innovative, easy to use “single shot” catheter ablation system to provide more long-lasting and durable ablations and reduce the rate of recurrence of Atrial Fibrillation (AFib) after pulmonary vein ablation (PVI).



ElectroPhysiology Frontiers was formed in 2019 by TechWald Holding S.p.A. and later received additional investments from Indaco Venture Partners SGR and Nocturnal Product Development LLC. Since the initiation of operations in 2019 prototypes have been built and pre-clinical testing is being performed.